Related references
Note: Only part of the references are listed.Cholesterol-Lowering Effect of Octaarginine-Appended β-Cyclodextrin in Npc1-Trap-CHO Cells
Keiichi Motoyama et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
Molecularly imprinted cyclodextrin nanosponges for the controlled delivery of L-DOPA: perspectives for the treatment of Parkinson's disease
Francesco Trotta et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
Neuroprotective Effects of Engineered Polymeric Nasal Microspheres Containing Hydroxypropyl-β-cyclodextrin on β-Amyloid (1-42)-Induced Toxicity
Ayfer Yalcin et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Back to the Future: A New Look at Hydroxypropyl Beta-Cyclodextrins
Milo Malanga et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Brain-Targeting Chemical Delivery Systems and Their Cyclodextrin-Based Formulations in Light of the Contributions of Marcus E. Brewster
Peter Buchwald et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Evaluation of the potential toxicity of unmodified and modified cyclodextrins on murine blood-brain barrier endothelial cells
Sergey Shityakov et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2016)
Preclinical Reversal of Atherosclerosis by FDA-Approved Compound that Transforms Cholesterol into an Anti-Inflammatory Prodrug''
Andrew R. Mendelsohn et al.
REJUVENATION RESEARCH (2016)
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming
Sebastian Zimmer et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Formulation, optimization, and pharmacodynamic evaluation of chitosan/phospholipid/β-cyclodextrin microspheres
Lu Shan et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
β-Cyclodextrins Decrease Cholesterol Release and ABC-Associated Transporter Expression in Smooth Muscle Cells and Aortic Endothelial Cells
Caroline Coisne et al.
FRONTIERS IN PHYSIOLOGY (2016)
Efficacy and ototoxicity of different cyclodextrins in Niemann-Pick C disease
Cristin D. Davidson et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Molecular Complex Composed of beta-Cyclodextrin-Grafted Chitosan and pH-Sensitive Amphipathic Peptide for Enhancing Cellular Cholesterol Efflux under Acidic pH
Yuki Takechi-Haraya et al.
BIOCONJUGATE CHEMISTRY (2015)
Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles
Sante Di Gioia et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
A novel trigger for cholesterol-dependent smooth muscle contraction mediated by the sphingosylphosphorylcholine-Rho-kinase pathway in the rat basilar artery: a mechanistic role for lipid rafts
Satoshi Shirao et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Molecular Dynamics Simulations of the Interaction of Beta Cyclodextrin with a Lipid Bilayer
Wasinee Khuntawee et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Early Statin Use and the Progression of Alzheimer Disease A Total Population-Based Case-Control Study
Feng-Cheng Lin et al.
MEDICINE (2015)
Genetic and Chemical Activation of TFEB Mediates Clearance of Aggregated α-Synuclein
Kiri Kilpatrick et al.
PLOS ONE (2015)
Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease
Charles H. Vite et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response
Fabrizio Montecucco et al.
VASCULAR PHARMACOLOGY (2015)
Masking the Bitter Taste of Injectable Lidocaine HCl Formulation for Dental Procedures
Yangjie Wei et al.
AAPS PHARMSCITECH (2015)
Complex lipid trafficking in Niemann-Pick disease type C
Marie T. Vanier
JOURNAL OF INHERITED METABOLIC DISEASE (2015)
Allopregnanolone Preclinical Acute Pharmacokinetic and Pharmacodynamic Studies to Predict Tolerability and Efficacy for Alzheimer's Disease
Ronald W. Irwin et al.
PLOS ONE (2015)
Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier
Melanie Kuntz et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Effects of oxysterols on the blood-brain barrier: Implications for Alzheimer's disease
Fabien Gosselet et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
β-Cyclodextrin and Curcumin, a Potent Cocktail for Disaggregating and/or Inhibiting Amyloids: A Case Study with α-Synuclein
Saurabh Gautam et al.
BIOCHEMISTRY (2014)
Cholesterol depletion induces transcriptional changes during skeletal muscle differentiation
Ana C. B. Possidonio et al.
BMC GENOMICS (2014)
Contribution of Intimal Smooth Muscle Cells to Cholesterol Accumulation and Macrophage-Like Cells in Human Atherosclerosis
Sima Allahverdian et al.
CIRCULATION (2014)
Human ABC Transporters at blood-CNS Interfaces as Determinants of CNS Drug Penetration
Catarina Chaves et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Molecular Mechanisms of Cellular Cholesterol Efflux
Michael C. Phillips
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Structural Modifications of Neuroprotective Anti-Parkinsonian (-)-N6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): An Effort toward the Improvement of in Vivo Efficacy of the Parent Molecule
Gyan Modi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Three suspected cases of sugammadex-induced anaphylactic shock
Tomonori Takazawa et al.
BMC ANESTHESIOLOGY (2014)
Highly Stabilized Curcumin Nanoparticles Tested in an In Vitro Blood-Brain Barrier Model and in Alzheimer's Disease Tg2576 Mice
Kwok Kin Cheng et al.
AAPS JOURNAL (2013)
Oxysterols decrease apical-to-basolateral transport of Aβ peptides via an ABCB1-mediated process in an in vitro Blood-brain barrier model constituted of bovine brain capillary endothelial cells
Julien Saint-Pol et al.
BRAIN RESEARCH (2013)
Amyloid-β Peptides, Alzheimer's Disease and the Blood-brain Barrier
Fabien Gosselet et al.
CURRENT ALZHEIMER RESEARCH (2013)
Liver X receptor modulators: a review of recently patented compounds (2009-2012)
Jon Loren et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Role of Cholesterol in APP Metabolism and Its Significance in Alzheimer's Disease Pathogenesis
M. Maulik et al.
MOLECULAR NEUROBIOLOGY (2013)
Self-assembling Modified β-Cyclodextrin Nanoparticles as Neuronal siRNA Delivery Vectors: Focus on Huntington's Disease
Bruno M. D. C. Godinho et al.
MOLECULAR PHARMACEUTICS (2013)
Computational microscopy of cyclodextrin mediated cholesterol extraction from lipid model membranes
Cesar A. Lopez et al.
SCIENTIFIC REPORTS (2013)
Specific Binding of a β-Cyclodextrin Dimer to the Amyloid β Peptide Modulates the Peptide Aggregation Process
Anna Wahlstrom et al.
BIOCHEMISTRY (2012)
β-Cyclodextrin-poly(β-Amino Ester) Nanoparticles for Sustained Drug Delivery across the Blood-Brain Barrier
Eun Seok Gil et al.
BIOMACROMOLECULES (2012)
Three cases of suspected sugammadex-induced hypersensitivity reactions
K. Godai et al.
BRITISH JOURNAL OF ANAESTHESIA (2012)
Synthesis of β-cyclodextrin conjugated superparamagnetic iron oxide nanoparticles for selective binding and detection of cholesterol crystals
Hongguang Li et al.
CHEMICAL COMMUNICATIONS (2012)
Cholesterol depletion by methyl-β-cyclodextrin enhances cell proliferation and increases the number of desmin-positive cells in myoblast cultures
Debora M. Portilho et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease
Jiaqi Yao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Sterol Transfer between Cyclodextrin and Membranes: Similar but Not Identical Mechanism to NPC2-Mediated Cholesterol Transfer
Leslie A. McCauliff et al.
BIOCHEMISTRY (2011)
Albumin nanoparticles carrying cyclodextrins for nasal delivery of the anti-Alzheimer drug tacrine
Barbara Luppi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
Distribution of Smooth Muscle Cells and Macrophages Expressing Scavenger Receptor BI/II in Atherosclerosis
Yukio Ishikawa et al.
Journal of Atherosclerosis and Thrombosis (2011)
Unesterified Cholesterol Accumulation in Late Endosomes/Lysosomes Causes Neurodegeneration and Is Prevented by Driving Cholesterol Export from This Compartment
Amal Aqul et al.
JOURNAL OF NEUROSCIENCE (2011)
Critical Role of Astroglial Apolipoprotein E and Liver X Receptor-α Expression for Microglial Aβ Phagocytosis
Dick Terwel et al.
JOURNAL OF NEUROSCIENCE (2011)
TFEB Links Autophagy to Lysosomal Biogenesis
Carmine Settembre et al.
SCIENCE (2011)
Alzheimer's Disease
Dennis J. Selkoe
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Molecular Mechanism of Cyclodextrin Mediated Cholesterol Extraction
Cesar A. Lopez et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Evaluation of the cytotoxicity of β-cyclodextrin derivatives: Evidence for the role of cholesterol extraction
T. Kiss et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression
Jonathan E. Feig et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Cyclodextrin overcomes the transport defect in nearly every organ of NPC1 mice leading to excretion of sequestered cholesterol as bile acid
Benny Liu et al.
JOURNAL OF LIPID RESEARCH (2010)
Altered cholesterol homeostasis contributes to enhanced excitotoxicity in Huntington's disease
Daniel del Toro et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Niemann-Pick disease type C
Marie T. Vanier
ORPHANET JOURNAL OF RARE DISEASES (2010)
Endocytosis of beta-cyclodextrins is responsible for cholesterol reduction in Niemann-Pick type C mutant cells
Anton I. Rosenbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cholesterol Homeostasis and High-Density Lipoprotein Formation in Arterial Smooth Muscle Cells
Sima Allahverdian et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2010)
Quaternary Ammonium β-Cyclodextrin Nanoparticles for Enhancing Doxorubicin Permeability across the In Vitro Blood-Brain Barrier
Eun Seok Gil et al.
BIOMACROMOLECULES (2009)
ATP-Binding Cassette Transporter A1 Expression and Apolipoprotein A-I Binding Are Impaired in Intima-Type Arterial Smooth Muscle Cells
Hong Y. Choi et al.
CIRCULATION (2009)
Pharmacokinetic evaluation and modeling of formulated levodopa intranasal delivery systems
Tae Kyung Kim et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Mucoadhesive microspheres for nasal administration of cyclodextrins
Elisabetta Gavini et al.
JOURNAL OF DRUG TARGETING (2009)
Specific Loss of Brain ABCA1 Increases Brain Cholesterol Uptake and Influences Neuronal Structure and Function
Joanna M. Karasinska et al.
JOURNAL OF NEUROSCIENCE (2009)
Chronic Cyclodextrin Treatment of Murine Niemann-Pick C Disease Ameliorates Neuronal Cholesterol and Glycosphingolipid Storage and Disease Progression
Cristin D. Davidson et al.
PLOS ONE (2009)
Reversal of defective lysosomal transport in NPC disease ameliorates liver dysfunction and neurodegeneration in the npc1-/- mouse
Benny Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
A Gene Network Regulating Lysosomal Biogenesis and Function
Marco Sardiello et al.
SCIENCE (2009)
Role of ATP-binding cassette transporters in brain lipid transport and neurological disease
Woojin Scott Kim et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production
Huaqi Xiong et al.
NEUROBIOLOGY OF DISEASE (2008)
The blood-brain barrier in health and chronic neurodegenerative disorders
Berislav V. Zlokovic
NEURON (2008)
Structure-activity relationships of amyloid beta-aggregation inhibitors based on curcumin: Influence of linker length and flexibility
Ashley A. Reinke et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2007)
Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-β-cyclodextrin in infants, children, and adolescents
Susan M. Abdel-Rahman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Cyclodextrins and their pharmaceutical applications
Thorsteinn Loftsson et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Cholesterol dysfunction in neurodegenerative diseases: Is Huntington's disease in the list?
Marta Valenza et al.
PROGRESS IN NEUROBIOLOGY (2006)
Pregnane X receptor (PXR) activation: A mechanism for neuroprotection in a mouse model of Niemann-Pick C disease
S. Joshua Langmade et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Effects of the cholesterol-lowering compound methyl-β-cyclodextrin in models of α-synucleinopathy
Pazit Bar-On et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Small molecule inhibitors of α-synuclein filament assembly
Masami Masuda et al.
BIOCHEMISTRY (2006)
Methylated β-cyclodextrin as P-gp modulators for deliverance of doxorubicin across an in vitro model of blood-brain barrier
S Tilloy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
ABCA1 and ABCG1 synergize to mediate cholesterol export to apoA-I
IC Gelissen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Microglia in the aging brain
Jessica R. Conde et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2006)
Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice
R Koldamova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Allopregnanolone treatment, both as a single injection or repetitively, delays demyelination and enhances survival of Niemann-Pick C mice
I Ahmad et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease
S Soumian et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
A quantitative proteomic analysis of growth factor-induced compositional changes in lipid rafts of human smooth muscle cells
DL MacLellan et al.
PROTEOMICS (2005)
2-hydroxypropyl-β-cyclodextrin (HP-β-CD):: A toxicology review
S Gould et al.
FOOD AND CHEMICAL TOXICOLOGY (2005)
Alzheimer disease β-amyloid activity mimics cholesterol oxidase
L Puglielli et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Genes of cholesterol metabolism in human atheroma - Overexpression of perilipin and genes promoting cholesterol storage and repression of ABCA1 expression
F Forcheron et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
The liver X receptor ligand T0901317 decreases amyloid β production in vitro and in a mouse model of Alzheimer's disease
T Koldamova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Behavior of α-, β-, and γ-cyclodextrins and their derivatives on an in vitro model of blood-brain barrier
V Monnaert et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Effects of γ- and hydroxypropyl-γ-cyclodextrins on the transport of doxorubicin across an in vitro model of blood-brain barrier
V Monnaert et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
ABCA1 expression in carotid atherosclerotic plaques
C Albrecht et al.
STROKE (2004)
Cyclodextrin-based pharmaceutics: Past, present and future
ME Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Niemann-Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone
LD Griffin et al.
NATURE MEDICINE (2004)
Two-site binding of β-cyclodextrin to the Alzheimer Aβ(1-40) peptide measured with combined PFG-NMR diffusion and induced chemical shifts
J Danielsson et al.
BIOCHEMISTRY (2004)
Cyclodextrins differentially mobilize free and esterified cholesterol from primary human foam cell macrophages
SM Liu et al.
JOURNAL OF LIPID RESEARCH (2003)
Plasma total cholesterol level as a risk factor for Alzheimer disease - The Framingham study
ZS Tan et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease
E Hockly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Antioxidants as treatment for neurodegenerative disorders
B Moosmann et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2002)
Per-6-substituted β-cyclodextrin libraries inhibit formation of β-amyloid-peptide (Aβ)-derived, soluble oligomers
JX Yu et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2002)
Drug transport to the brain:: Key roles for the efflux pump P-glycoprotein in the blood-brain barrier
M Demeule et al.
VASCULAR PHARMACOLOGY (2002)
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
SB Joseph et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease
F Camargo et al.
LIFE SCIENCES (2001)
A cholesterol-lowering drug reduces β-amyloid pathology in a transgenic mouse model of Alzheimer's disease
LM Refolo et al.
NEUROBIOLOGY OF DISEASE (2001)
Alpha-synuclein and neurodegenerative diseases
M Goedert
NATURE REVIEWS NEUROSCIENCE (2001)
Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
K Fassbender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Tight junctions of the blood-brain barrier
U Kniesel et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2000)
Share Paper
